US 5,665,581 A · Attenuation of fungal virulence by synthetic infectious mycovirus transcripts

Abstract

This invention is directed to naturally virulent fungi which have cells transfected with the coding strand of a mycovirus RNA and which have reduced ability to cause disease in plants, and to compositions and methods of treatment of fungal disease with these fungi.

Claims2

Dependent claims

A method for artificially inserting into a fungal cell a selected mycovirus RNA, which method comprises obtaining the coding strand of said mycovirus RNA, and causing said coding strand to enter said fungal cell by performing electroporation.

Dependencies are inferred from the claim text.

Facts

Application

08/253,451Filed 3 Jun 1994

Granted

9 Sep 1997

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A01N 63/60
Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances…:…
C12N 15/80
Vectors or expression systems specially adapted for eukaryotic hosts: for fungi
C12N 2720/00022
Details: new viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Attenuation of fungal virulence by synthetic infectious mycovirus transcripts

Life of this patent

Abstract

Claims2

Attenuation of fungal virulence by synthetic infectious mycovirus transcripts

Life of this patent

Abstract

Claims2